Incyte Granted License To Gene Expression Analysis Technology

Incyte Pharmaceuticals, Inc. has been granted an exclusive license to a pioneering gene expression analysis technology from the Montefiore Medical Center. The technology, which was invented by Dr. Leonard Augenlicht and patented in 1991 (U.S. Patent No. 4,981,783), covers methods for measuring gene expression using a defined array.

"This patent, based on the pioneering research of Dr. Augenlicht, is one of the earliest patents filed in the field of gene expression analysis," said Dr. Randy Scott, president and chief scientific officer of Incyte. "The methods covered have broad applications in disease gene expression and enhance Incyte's growing intellectual property portfolio of microarray technologies."

For more information: Denise Gilbert, chief financial officer, Incyte Pharmaceuticals, Inc. 3174 Porter Drive, Palo Alto, CA 94304. Telephone: 650-845-4515.